MedPath

Determination of Lung Maturity and Prediction of RDS at Birth

Completed
Conditions
Premature Birth
RDS
Registration Number
NCT02076126
Lead Sponsor
Henrik Axel Verder
Brief Summary

The overall objective is to identify quickly after birth the preterm infants who will develop respiratory distress syndrome (RDS) for the purpose of treating them as early as possible with surfactant, to reduce, and if possible, to avoid sequelae, including long-term oxygen treatment.

We have therefore developed a quick test, which we believe will be ideal for this type of diagnostics, and will now test the method in a preclinical trial.

Detailed Description

In at least 135 preterm infants with gestational age 24-32 weeks we will collect gastric aspirate and hypopharyngeal secretion. The infants are stratified into three groups: gestational age 24-25 weeks, 26-29 weeks and 30-31 weeks.

The aspirates will be frozen at -20 centigrade and lecithin-sphingomyelin ratio (L/S) will be analysed retrospectively using Fourier Transform Infrared Spectroscopy.

The infants will be monitored for the first five days with regard to possible development of RDS.

Clinical and biochemical data will be compared retrospectively.

There a no intervention procedures.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
145
Inclusion Criteria
  • Preterm infants with gestational ages of 24 (24+0) to 32 (31+6) weeks.
  • Age < ½ hour
Exclusion Criteria
  • Lack of informed consent
  • lack of aspirate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
RDS5 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Holbaek Sygehus

🇩🇰

Holbaek, Denmark

© Copyright 2025. All Rights Reserved by MedPath